Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens – PR Newswire (press release)
GuruFocus.com |
Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens
PR Newswire (press release) HORSHAM, Pa., May 2, 2018 /PRNewswire/ — Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a definitive agreement under which it will acquire BeneVir Biopharm, Inc … HC2 Announces Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech, Inc … |
